Literature DB >> 25688454

How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?

Robert J Smith1, Austin S Kilaru1,2, Jeanmarie Perrone1,3, Breah Paciotti1, Frances K Barg4, Sarah M Gadsden4, Zachary F Meisel1.   

Abstract

OBJECTIVE: The prescription opioid epidemic is currently responsible for the greatest number of unintentional deaths in the United States. One potential strategy for decreasing this epidemic is implementation of state-based Prescription Drug Monitoring Programs (PDMPs), which are designed for providers to identify patients who "doctor shop" for prescriptions. Emergency medicine physicians are some of the most frequent PDMP users and opioid prescribers, but little is known about how they actually use PDMPs, for which patients, and for what reasons.
METHODS: We conducted and transcribed semistructured qualitative interviews with 61 physicians at a national academic conference in October 2012. Deidentified transcripts were entered into QSR NVivo 10.0, coded, and analyzed for themes using modified grounded theory.
RESULTS: There is variation in pattern and frequency of PDMP access by emergency physicians. Providers rely on both structural characteristics of the PDMP, such as usability, and also their own clinical gestalt impression when deciding to use PDMPs for a given patient encounter. Providers use the information in PDMPs to alter clinical decisions and guide opioid prescribing patterns. Physicians describe alternative uses for the databases, such as improving their ability to facilitate discussions on addiction and provide patient education.
CONCLUSION: PDMPs are used for multiple purposes, including identifying opioid misuse and enhancing provider-patient communication. Given variation in practice, standards may help direct indication and manner of physician use. Steps to minimize administrative barriers to PDMP access are warranted. Finally, alternative PDMP uses should be further studied to determine their appropriateness and potentially expand their role in clinical practice. Wiley Periodicals, Inc.

Entities:  

Keywords:  Emergency Care; Healthcare Providers; Prescription Monitoring Programs; Prescription Opioids

Mesh:

Substances:

Year:  2015        PMID: 25688454      PMCID: PMC4478227          DOI: 10.1111/pme.12700

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  15 in total

Review 1.  Qualitative research in health care. Assessing quality in qualitative research.

Authors:  N Mays; C Pope
Journal:  BMJ       Date:  2000-01-01

2.  Users' guides to the medical literature: XXIII. Qualitative research in health care B. What are the results and how do they help me care for my patients? Evidence-Based Medicine Working Group.

Authors:  M K Giacomini; D J Cook
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

3.  Awareness and utilization of a prescription monitoring program among physicians.

Authors:  Lance Feldman; Kristi Skeel Williams; John Coates; Michele Knox
Journal:  J Pain Palliat Care Pharmacother       Date:  2011-09-21

4.  Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program.

Authors:  Jeanmarie Perrone; Lewis S Nelson
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

5.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

6.  How does use of a prescription monitoring program change medical practice?

Authors:  Traci C Green; Marita R Mann; Sarah E Bowman; Nickolas Zaller; Xaviel Soto; John Gadea; Catherine Cordy; Patrick Kelly; Peter D Friedmann
Journal:  Pain Med       Date:  2012-07-30       Impact factor: 3.750

7.  Physician perspectives on a pilot prescription monitoring program.

Authors:  Kirsten Barrett; Ashby Watson
Journal:  J Pain Palliat Care Pharmacother       Date:  2005

8.  Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.

Authors:  Jessica M Irvine; Sara E Hallvik; Christi Hildebran; Miguel Marino; Todd Beran; Richard A Deyo
Journal:  J Pain       Date:  2014-04-29       Impact factor: 5.820

9.  CDC grand rounds: prescription drug overdoses - a U.S. epidemic.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-13       Impact factor: 17.586

10.  A statewide prescription monitoring program affects emergency department prescribing behaviors.

Authors:  David F Baehren; Catherine A Marco; Danna E Droz; Sameer Sinha; E Megan Callan; Peter Akpunonu
Journal:  Ann Emerg Med       Date:  2010-01-04       Impact factor: 5.721

View more
  17 in total

Review 1.  Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Authors:  Rebecca L Haffajee; Cecelia A French
Journal:  Curr Opin Psychol       Date:  2019-02-04

2.  Clinicians' Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making.

Authors:  Gillian J Leichtling; Jessica M Irvine; Christi Hildebran; Deborah J Cohen; Sara E Hallvik; Richard A Deyo
Journal:  Pain Med       Date:  2017-06-01       Impact factor: 3.750

3.  National Variation in Opioid Prescribing and Risk of Prolonged Use for Opioid-Naive Patients Treated in the Emergency Department for Ankle Sprains.

Authors:  M Kit Delgado; Yanlan Huang; Zachary Meisel; Sean Hennessy; Michael Yokell; Daniel Polsky; Jeanmarie Perrone
Journal:  Ann Emerg Med       Date:  2018-07-24       Impact factor: 5.721

4.  The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area.

Authors:  Susan L Calcaterra; Maria Butler; Katie Olson; Joshua Blum
Journal:  J Addict Med       Date:  2022 May-Jun 01       Impact factor: 4.647

5.  Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.

Authors:  Yuhua Bao; Katherine Wen; Phyllis Johnson; Philip J Jeng; Zachary F Meisel; Bruce R Schackman
Journal:  Health Aff (Millwood)       Date:  2018-10       Impact factor: 6.301

6.  A Randomized Trial Testing the Effect of Narrative Vignettes Versus Guideline Summaries on Provider Response to a Professional Organization Clinical Policy for Safe Opioid Prescribing.

Authors:  Zachary F Meisel; Joshua P Metlay; Lauren Sinnenberg; Austin S Kilaru; Anne Grossestreuer; Frances K Barg; Frances S Shofer; Karin V Rhodes; Jeanmarie Perrone
Journal:  Ann Emerg Med       Date:  2016-04-29       Impact factor: 5.721

7.  Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention.

Authors:  Mary Jo Larson; Cheryl Browne; Ruslan V Nikitin; Nikki R Wooten; Sarah Ball; Rachel Sayko Adams; Kelly Barth
Journal:  Subst Abus       Date:  2018-05-04       Impact factor: 3.716

8.  Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.

Authors:  Brandon C Maughan; Marcus A Bachhuber; Nandita Mitra; Joanna L Starrels
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

9.  Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.

Authors:  Jenna L McCauley; Renata S Leite; Cathy L Melvin; Roger B Fillingim; Kathleen T Brady
Journal:  Subst Abus       Date:  2015-12-16       Impact factor: 3.716

10.  Improving the design of California's prescription drug monitoring program.

Authors:  Mustafa I Hussain; Ariana M Nelson; Gregory Polston; Kai Zheng
Journal:  JAMIA Open       Date:  2019-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.